Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor

Abstract

The present study suggests a new potential of endothelial survival factor, COMP-Ang-1, as an antihypertensive agent that effectively reduces the hypertension-associated cardiovascular and renal damage, as well as prevents the further elevation of BP.